SkyePharma PLC

This edition of the Pink Sheet ’s Quality Lowdown takes a look at some of the bumps in the road and decisions made along the way in recent chemistry, manufacturing and controls reviews as assessors i

Top Of The Market Indicator Ask any European private biotech company just a year ago on its plans for fundraising and a NASDAQ IPO would probably have figured highly in the answer. Since the start of

UK/US-based Theragnostics Ltd. is developing radiopharmaceuticals for the treatment and diagnosis of cancer that may be easier to administer than current products, have been shown to deliver cytotoxic

Three years after receiving a "complete response letter" for its Exparel (bupivacaine liposome injectable suspension) supplemental new drug application for use as a nerve block, Pacira Pharmaceuti